|
Scientific and Diagnostic Instruments and Systems
AIA®-1800 | AIA®-360 | AIA®-21 | AIA®-600II | AIA®-PACK | HLC®-723GHb G7 | HLC®-726VMA II | CCP & 8020 series | HLC® series | TOYOPEARL® | TSK-GEL®
|
Product Name |
AIA®-1800 |
|
Generic Name |
Automated enzyme immunoassay system |
|
Product Overview |
The AIA®-1800, successor of AIA-21 (NexIA), realizes 50% up throughput (180 tests per hour) at running any combination of AIA® ST assays. The AIA®-1800 maximizes throughput by using random access and continuous process without workflow interruptions. Customize the automatic reschedule, automatic rerun, and automatic reflex testing by specimen and analyte for true result review by exception. The AIA®-1800 allows you to meet your laboratory workload requirements.
The AIA®-1800 utilizes all parameters in our comprehensive menu. AFP, CEA, PA, PAP, CA19-9 (SLa), CA125 (OVCA), CA15-3 (27.29), FER, TSH, T4, FT4, T-U, TT3, FT3, TPOAb, TgAB, E2, PRL, HCG, ßHCG, LH, FSH, PROG, Testosterone, CKMB, Folate, B12, c-Tnl, MYO, BNP, HBsAg, HBsAb, HBcAb, HBeAg, HBeAb, IRI, C-pep, CORT, IgE, BMG, HGH.
*Not all tests may be available in all countries due to local registration requirements. |
Typical properties / Grades
|
Mode of operation |
True random access |
|
Capacity |
180 tests/hour |
|
Interface |
RS232C (Two-way-communication)
Ethernet |
|
Detector system |
Top-to-top fluorescence detection |
|
Assay methodology |
One-step and two-step sandwich and competitive EIA |
|
Product Name |
AIA®-360 |
|
Generic Name |
Automated enzyme immunoassay system |
|
Product Overview |
Its compact and light weight design (40cm x 40cm x 52cm, 29kg) is suitable for physicians office laboratories, work-stations for small hospitals, cardiac and specialty testing.
The AIA®-360 is fully automated with continuous random access. The touch screen user interface provides easy access to screen associated with daily operations. The operator may load bar-code primary tubes or sample cups directly on the system.
Once samples and test cups are loaded, the operator presses START and walk away.
The AIA®-360 utilizes the same 10 minutes incubation, ST reagents as TOSOH’s AIA-600II, AIA-21(NexIA), and AIA-1800. With a throughput of 36 tests par hour, the AIA®-360 reports its first result in approximately 19 minutes.
|
Typical properties / Grades
|
Mode of operation |
True random access |
|
Capacity |
36 tests/hour |
|
Interface |
RS232C (Data upload to host only) |
|
Detector system |
Top-to-top fluorescence detection |
|
Assay methodology |
One-step sandwich and competitive EIA |
| Product name |
AIA®-21 |
| Generic name |
Fully automated random access enzyme immunoassay system |
| Product Overview |
Our unique diagnostic systems have revolutionized immunochemistry and broadened its definition. While conventional systems are comprised of test tubes, large beads, colorimetric reaction, and batch analysis, Tosoh's systems make use of dry stable test packs, magnetic microbeads, rate fluorescence and random access analysis utilizing monoclonal antibody technology. All results on patient samples are available at once, in less time, with less labor - revolutionizing the way immunoassays are performed. All this, plus a comprehensive assay menu: PRL, HCG, LH, FSH, E2, PROG, CORT, FER, IRI, CPep, AFP, CEA, ßHCG, PAP, PA, CA19-9 (SLa), CA125 (OVCA), TSH, T4, FT4, T-U, TT3, FT3, TPOAb, TgAB, IgE, BMG, HGH, CKMB, HBsAg, Folate, B12, c-Tnl, MYO, CA15-3 (BRCA). |
Typical properties / Grades
| Mode of operation |
True random access |
| Capacity |
120 tests/hour, analyte independent |
| Interface |
Bidirectional RS232C |
| Detector system |
Top-to-top multi channel fluorescence detection |
| Assay methodology |
One-step sandwich and competitive EIA |
|
|
Product name |
AIA®-600II |
|
Generic name |
Fully automated random access enzyme immunoassay system |
|
Product Overview |
This diagnostic system offers the same labor-saving benefits as the AIA®-21 in a compact benchtop package. The AIA®-600II uses the same test packs and has the same comprehensive menu as the AIA®-21. This completely automated system is both an excellent stand-alone solution for small laboratories, and an ideal backup system for the AIA®-21 in larger laboratories |
Typical properties / Grades
|
Mode of operation |
True random access |
|
Capacity |
60 tests/hour |
|
Interface |
Bidirectional RS232C |
|
Detector system |
Top-to-top fluorescence detection |
|
Assay methodology |
One-step and two-step sandwich and competitive EIA |
|
Product name |
AIA®-PACK |
|
Generic name |
Reagent system |
|
Product Overview |
Tosoh's reagent system used with the AIA®-600II and AIA®-21 is completely self-contained within our AIA®-PACK test cups. These test cups contain all of the necessary components to perform immune-reactions: magnetic microbeads, monoclonal antibodies and conjugate. The same standardized procedure is used for all assays on the AIA® systems, allowing the labor saving benefit of true random access. Quality reagents, automated procedures and precisely controlled reaction conditions are the basis for the consistent performance of our AIA® systems-meeting laboratory needs for dependability and versatility. |
|
|
|
Product name |
HLC®-723GHb G7 |
|
Generic name |
Fully automated glycohemoglobin analyzer |
|
Product Overview |
It is generally known that GHb (glycohemoglobin) is grouped into A1a, A1b, and A1c categories according to the kind of glucose so combined. Measurement of GHb is widely utilized today as an index for diabetic screening tests and also as a therapeutical index for the long-term blood glucose control of diabetes mellitus. HLC®-723GHb G7 is a fully automated, high performance liquid chromatography system designed to measure GHb accurately and rapidly. It is also used for quantitative and qualitative analysis of HbF, which cannot be easily measured by conventional methods. Highly reliable data can therefore be obtained by utilizing this system to its widest range of applicationsZED. |
|
Product name |
HLC®-726VMAII |
|
Generic name |
Fully automated VMA/HVA analyzer |
|
Product Overview |
A neuroblastoma is one type of malignant tumor which may occur in children. It can be detected by measuring the amounts of vanillylmandelic acid (VMA) and homovanillic acid (HVA), both of which are final metabolites of catecholamine in urine. A mass-screening test for VMA/HVA can now be carried out on neonates. The HLC®-726VMAII is a fully automated specialty system for measuring VMA and HVA concentrations simultaneously and accurately, as creatinine (CRN) concentration. The HLC®-726VMAII is also expected to be useful not only in the above mass-screening, but also in the clinical inspection of neuroblastoma and pheochromocytoma. |
| | |